Provided by Tiger Fintech (Singapore) Pte. Ltd.

Islamic Stocks

3,618.35
+37.931.06%
Number of Gainers:13
Number of Losers:4
Number of Flat:- -
PE:- -
High:3,655.71
Open:3,587.93
Low:3,587.93
Close:3,580.43
Loading ...

Johnson & Johnson (NYSE:JNJ) Gains FDA Approval For IMAAVY™ To Treat Myasthenia Gravis

Simply Wall St.
·
01 May

Nvidia Stock Is Pulling Back Today. Here's Why Investors Are Nervous.

Motley Fool
·
01 May

Why ConocoPhillips, Chevron, and Cheniere Energy Stocks All Dropped Today

Motley Fool
·
01 May

Global Equities Roundup: Market Talk

Dow Jones
·
01 May

Musk “Chose Tesla (TSLA)” at a Crucial Time, Well-Known Analyst Says

Insider Monkey
·
01 May

Why Tesla Stock Hit the Brakes Today

Motley Fool
·
01 May

BREAKINGVIEWS-Silicon Valley’s Trump trade broke too many things

Reuters
·
01 May

Exxon Mobil says working to resolve operational issue at refinery in Joliet, IL

Reuters
·
30 Apr

Exxon Mobil Says Working to Resolve Operational Issue That Occurred on Monday at Joliet Refinery

THOMSON REUTERS
·
30 Apr

Meta Platforms, Inc. (META): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

Insider Monkey
·
30 Apr

Google Hoping to Enter Gemini Distribution Agreement by Mid-Year, Google CEO Sundar Pichai Testifies at Trial

THOMSON REUTERS
·
30 Apr

Waymo and Toyota partner to go after Tesla with personal self-driving vehicles

Electrek
·
30 Apr

Sinclair Names Jeff Blackburn Chairman and CEO of Tennis Channel

Business Wire
·
30 Apr

Pfizer : Bofa Global Research Raises Price Objective to $27 From $26

THOMSON REUTERS
·
30 Apr

BUZZ-Hess falls on lower first-quarter profit

Reuters
·
30 Apr

Company News for Apr 30, 2025

Zacks
·
30 Apr

Boost Your Portfolio With These 5 Low Price-to-Book Stocks

Zacks
·
30 Apr

Meta, Microsoft, Starbucks, Visa: Stocks to watch today

Quartz
·
30 Apr

US FDA approves J&J's immune disorder drug

Reuters
·
30 Apr

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)

PR Newswire
·
30 Apr